Curevac, Novavax start phase III COVID-19 clinical trials in Mexico, says government

Mexico's foreign minister Marcelo Ebrard said on Friday that CureVac and Novavax have begun their phase III clinical trials in Mexico for a COVID-19 vaccine.

China's CanSino Biologics Inc is due to present the results of its phase III trial, Ebrard also said.